Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: A population-based case-control study

Acta Diabetologica

Volumn 40, Issue SUPPL. 2, 2003, Pages

  Strokov, I A ^a   Bursa, T R ^b   Drepa, O I ^b   Zotova, E V ^c   Nosikov, V V ^c   Ametov, A S ^b  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Psychological Institute of Russian Education Academy   (Russian Federation)

^c STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

Author keywords

Diabetic polyneuropathy; Genetic susceptibility; Superoxide dismutase genes

Indexed keywords

ALANINE; ANTIOXIDANT; ARGININE; SUPEROXIDE DISMUTASE; VALINE;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE PREDISPOSITION; GENE; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC EXAMINATION; OXIDATIVE STRESS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOD2 GENE; SOD3 GENE;

EID: 0346734336     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-003-0123-x     Document Type: Conference Paper

References (29)

1. Vinik AI, Park TS, Stansberry KB et al (2000) Diabetic neuropathies. Diabetologia 43:957-973
2. Low PA, Nickander KK, Tritschler HJ (1997) The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46[Suppl 2]:S38-S42
3. Rosen P, Nawroth PP, King G et al (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society, Diabetes Metab Res Rev 17(3):189-212
4. Vlassara H (1992) Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 41:52-56
5. Manes CH, Papazoglou N, Sossidoi Y et al (2002) Prevalence of diabetic neuropathy and foot ulceration: identification of potential risk factors. A population-based study. Wounds 14:11-15
6. Ramachandran A, Snehalatha C, Sasikala K et al (2000) Vascular complications in young Asian Indian patients with type 1 diabetes: Diabetes Res Clin Pract 48:51-56
7. Tesfaye S, Stevens LK, Stephenson JM et al (1996) Prevalence of diabetic peripherial neuropathy and its relation to glycemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39:1377-1384
8. Concannon P, Gogolin-Ewens KJ, Hinds DA et al (1998) A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 19:292-296
9. Mein CA, Esposito L, Dunn MG et al (1998) A search for type 1 dibetes susceptibility genes in families from the United Kingdom. Nat Genet 19:297-300
10. Heesom A, Millward A, Demaine A (1998) Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene. J Neurol Neurosurg Psychiatry 64:213-216
11. Vague P, Dufayet D,Coste T et al (1997) Association of diabetic neuropathy with Na/K ATPase gene polymorphism. Diabetologia 40:506-511
12. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T et al (1996) Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 226:561-565
13. Sandstrom J, Nilsson P, Karlsson K, Marklund SL (1994) 10-Fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem 269:19163-19166
14. - (1988) Consensus statement report and recommendations of the San Antonio Conference on diabetic neuropathy. American Diabetes Association, American Academy of Neurology. Diabetes Care 11:592-598
15. Ziegler D, Hanefeld M, Ruhnau KJ et al (1995) Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38:1425-1433
16. Dyck JB, Dyck PJ (1997) Diabetic polyneuropathy. In: Dyck PJ (ed) Diabeticneuropathy. WB Saunders, Philadelphia, pp 264-267
17. Dyck PJ, Davies JL, Litchy WJ et al (1997) Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49:229-230
18. Kimura J (1989) Electrodiagnosis in disease of nerve and muscle. Principles and practice, 2nd edn. F.A. Davis, Philadelphia, pp 126-131
19. Budowle B, Baechtel FS (1990) Modifications to improve the effectiveness of restriction fragment length polymorphism. Appl Electrophor 1:181-187
20. Melton JL, Dyck PJ (1997) Diabetic polyneuropathy. Epidemiology. In: Dyck PJ (ed) Diabetic neuropathy. WB Saunders, Philadelphia, pp 249-252
21. Freeman BA, Young SL, Crapo JD (1983) Liposome mediated augmentation of superoxide dismutase in endothelial cells presents oxygen injury. J Biol Chem 258:12534-12542
22. Ceriello A, Morocutti A, Mercuri F et al (2000) Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 46:2170-2177
23. Rosenblum JS, Gilula NB, Lerner RA (1996) On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA 93:4471-4473
24. Hiroi S, Harada H, Nishi H et al (1999) Polymorphisms in the SOD2 and HLA-DRBI genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 261:332-339
25. Martinez-Blasco A, Bosch-Morell F, Trenor C et al (1998) Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved. Biofactors 8:41-43
26. Jenner P (1996) Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol Biol (Paris) 44:57-64
27. Folz RJ, Peno-Green L, Crapo JD (1994) Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum Mol Genet 3:2251-2254
28. Wang XL, Adachi T, Sim AS, Wilcken DE (1998) Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol 18:1915-1921
29. Stevens MJ, Obrosova I, Cao X et al (2000) Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006-1015